3-N-Butylphthalide
Icosapent ethyl may increase the antiplatelet activities of Butylphthalide.
Abciximab
Icosapent ethyl may increase the anticoagulant activities of Abciximab.
Acenocoumarol
Icosapent ethyl may increase the anticoagulant activities of Acenocoumarol.
Advertisement
Acetyl salicylate
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Acetylsalicylic acid.
Aloxiprin
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Aloxiprin.
alpha Tocopherol
Vitamin E may increase the antiplatelet activities of Icosapent ethyl.
Advertisement
Alprostadil
Alprostadil may increase the antiplatelet activities of Icosapent ethyl.
Alteplase
Icosapent ethyl may increase the anticoagulant activities of Alteplase.
Aminosalicylic Acid
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Aminosalicylic Acid.
Advertisement
Anagrelide
Icosapent ethyl may increase the anticoagulant activities of Anagrelide.
Ancrod
Icosapent ethyl may increase the anticoagulant activities of Ancrod.
Anistreplase
Icosapent ethyl may increase the anticoagulant activities of Anistreplase.
Antithrombin III
Icosapent ethyl may increase the anticoagulant activities of Antithrombin III human.
Antithrombin III, Human
Icosapent ethyl may increase the anticoagulant activities of Antithrombin III human.
Apixaban
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Apixaban.
Ardeparin
Icosapent ethyl may increase the anticoagulant activities of Ardeparin.
Argatroban
Icosapent ethyl may increase the anticoagulant activities of Argatroban.
Argatroban Anhydrous
Icosapent ethyl may increase the anticoagulant activities of Argatroban.
Aspirin
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Acetylsalicylic acid.
Astaxanthin
Icosapent ethyl may increase the anticoagulant activities of Astaxanthin.
Azelastine
Azelastine may increase the antiplatelet activities of Icosapent ethyl.
Balsalazide
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Balsalazide.
Becaplermin
Icosapent ethyl may increase the anticoagulant activities of Becaplermin.
Bemiparin
Icosapent ethyl may increase the anticoagulant activities of Bemiparin.
Bivalirudin
Icosapent ethyl may increase the anticoagulant activities of Bivalirudin.
Cangrelor
Icosapent ethyl may increase the anticoagulant activities of Cangrelor.
Certoparin
Icosapent ethyl may increase the anticoagulant activities of Certoparin.
Cilostazol
Icosapent ethyl may increase the anticoagulant activities of Cilostazol.
Citric Acid
Icosapent ethyl may increase the anticoagulant activities of Citric Acid.
Citric Acid, Anhydrous
Icosapent ethyl may increase the anticoagulant activities of Citric Acid.
Clopidogrel
Icosapent ethyl may increase the anticoagulant activities of Clopidogrel.
COLLAGENASE
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Collagenase clostridium histolyticum.
collagenase Clostridium histolyticum
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Collagenase clostridium histolyticum.
Dabigatran Etexilate
Icosapent ethyl may increase the anticoagulant activities of Dabigatran etexilate.
Dalteparin
Icosapent ethyl may increase the anticoagulant activities of Dalteparin.
Danaparoid
Icosapent ethyl may increase the anticoagulant activities of Danaparoid.
Dasatinib
Dasatinib may increase the anticoagulant activities of Icosapent ethyl.
Dasatinib Anhydrous
Dasatinib may increase the anticoagulant activities of Icosapent ethyl.
Defibrotide
Icosapent ethyl may increase the anticoagulant activities of Defibrotide.
Deoxycholate
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Deoxycholic Acid.
Deoxycholic Acid
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Deoxycholic Acid.
Desirudin
Icosapent ethyl may increase the anticoagulant activities of Desirudin.
Dextran
Icosapent ethyl may increase the anticoagulant activities of Dextran.
Dextran 40
Icosapent ethyl may increase the anticoagulant activities of Dextran 40.
Dextran 70
Icosapent ethyl may increase the anticoagulant activities of Dextran 70.
Dextran 75
Icosapent ethyl may increase the anticoagulant activities of Dextran 75.
Dicumarol
Icosapent ethyl may increase the anticoagulant activities of Dicoumarol.
Diflunisal
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Diflunisal.
Dipyridamole
Icosapent ethyl may increase the anticoagulant activities of Dipyridamole.
Drotrecogin Alfa
Icosapent ethyl may increase the anticoagulant activities of Drotrecogin alfa.
Edetic Acid
Icosapent ethyl may increase the anticoagulant activities of Edetic Acid.
Edoxaban
Icosapent ethyl may increase the anticoagulant activities of Edoxaban.
Enoxaparin
Icosapent ethyl may increase the anticoagulant activities of Enoxaparin.
Enoxaparin sodium
Icosapent ethyl may increase the anticoagulant activities of Enoxaparin.
Epinastine
Epinastine may increase the antiplatelet activities of Icosapent ethyl.
Epoprostenol
Icosapent ethyl may increase the anticoagulant activities of Epoprostenol.
Eptifibatide
Icosapent ethyl may increase the anticoagulant activities of Eptifibatide.
Ethylenediaminetetraacetate
Icosapent ethyl may increase the anticoagulant activities of Edetic Acid.
Ferulic Acid
Icosapent ethyl may increase the anticoagulant activities of Ferulic acid.
Fluindione
Icosapent ethyl may increase the anticoagulant activities of Fluindione.
Fondaparinux
Icosapent ethyl may increase the anticoagulant activities of Fondaparinux.
Fondaparinux sodium
Icosapent ethyl may increase the anticoagulant activities of Fondaparinux sodium.
Glucosamine
Glucosamine may increase the antiplatelet activities of Icosapent ethyl.
Heparin
Icosapent ethyl may increase the anticoagulant activities of Heparin.
Hydroxytyrosol
Icosapent ethyl may increase the antiplatelet activities of Hydroxytyrosol.
Ibritumomab Tiuxetan
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Ibritumomab tiuxetan.
Ibrutinib
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Icosapent ethyl.
Ifenprodil
Icosapent ethyl may increase the antiplatelet activities of Ifenprodil.
Iloprost
Icosapent ethyl may increase the anticoagulant activities of Iloprost.
Indobufen
Icosapent ethyl may increase the anticoagulant activities of Indobufen.
Ketanserin
Icosapent ethyl may increase the antiplatelet activities of Ketanserin.
Lepirudin
Icosapent ethyl may increase the anticoagulant activities of Lepirudin.
Mesalamine
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Mesalazine.
Methyl Salicylate
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Methyl salicylate.
Milrinone
Milrinone may increase the antiplatelet activities of Icosapent ethyl.
Nadroparin
Icosapent ethyl may increase the anticoagulant activities of Nadroparin.
Nimesulide
Nimesulide may increase the antiplatelet activities of Icosapent ethyl.
Obinutuzumab
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Obinutuzumab.
Olsalazine
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Olsalazine.
Omega-3 Fatty Acids
Omega-3 fatty acids may increase the antiplatelet activities of Icosapent ethyl.
Parnaparin
Icosapent ethyl may increase the anticoagulant activities of Parnaparin.
Pentaerythritol Tetranitrate
Icosapent ethyl may increase the anticoagulant activities of Pentaerythritol Tetranitrate.
Pentosan Polysulfate
The risk or severity of adverse effects can be increased when Pentosan Polysulfate is combined with Icosapent ethyl.
Pentoxifylline
Pentoxifylline may increase the antiplatelet activities of Icosapent ethyl.
Phenindione
Icosapent ethyl may increase the anticoagulant activities of Phenindione.
Phenprocoumon
Icosapent ethyl may increase the anticoagulant activities of Phenprocoumon.
Phospholipids
Omega-3 fatty acids may increase the antiplatelet activities of Icosapent ethyl.
Plasmin
Icosapent ethyl may increase the anticoagulant activities of Fibrinolysin.
Prasugrel
Icosapent ethyl may increase the anticoagulant activities of Prasugrel.
protein C, human
Icosapent ethyl may increase the anticoagulant activities of Protein C.
protein S, human
Icosapent ethyl may increase the anticoagulant activities of Protein S human.
Protocatechualdehyde
Icosapent ethyl may increase the anticoagulant activities of Protocatechualdehyde.
Resveratrol
Resveratrol may increase the antiplatelet activities of Icosapent ethyl.
Reteplase
Icosapent ethyl may increase the anticoagulant activities of Reteplase.
Reviparin
Icosapent ethyl may increase the anticoagulant activities of Reviparin.
Reviparin sodium
Icosapent ethyl may increase the anticoagulant activities of Reviparin.
Rivaroxaban
Icosapent ethyl may increase the anticoagulant activities of Rivaroxaban.
Rosiglitazone
Icosapent ethyl may increase the anticoagulant activities of Rosiglitazone.
Salicylic Acid
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Salicylic acid.
Selexipag
Icosapent ethyl may increase the anticoagulant activities of Selexipag.
Sevoflurane
Sevoflurane may increase the antiplatelet activities of Icosapent ethyl.
Streptokinase
Icosapent ethyl may increase the anticoagulant activities of Streptokinase.
Tenecteplase
Icosapent ethyl may increase the anticoagulant activities of Tenecteplase.
Ticagrelor
Icosapent ethyl may increase the anticoagulant activities of Ticagrelor.
Ticlopidine
Icosapent ethyl may increase the anticoagulant activities of Ticlopidine.
Tinzaparin
Icosapent ethyl may increase the anticoagulant activities of Tinzaparin.
Tinzaparin sodium
Icosapent ethyl may increase the anticoagulant activities of Tinzaparin.
Tipranavir
Tipranavir may increase the antiplatelet activities of Icosapent ethyl.
Tirofiban
Icosapent ethyl may increase the anticoagulant activities of Tirofiban.
Tositumomab
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Tositumomab.
Tranilast
Tranilast may increase the antiplatelet activities of Icosapent ethyl.
Trapidil
Icosapent ethyl may increase the antiplatelet activities of Trapidil.
Treprostinil
Icosapent ethyl may increase the anticoagulant activities of Treprostinil.
Triflusal
Icosapent ethyl may increase the anticoagulant activities of Triflusal.
Trolamine Salicylate
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Trolamine salicylate.
Troxerutin
Icosapent ethyl may increase the anticoagulant activities of Troxerutin.
Urokinase
Icosapent ethyl may increase the anticoagulant activities of Urokinase.
Vitamin E
Vitamin E may increase the antiplatelet activities of Icosapent ethyl.
Vorapaxar
Icosapent ethyl may increase the anticoagulant activities of Vorapaxar.
Warfarin
Icosapent ethyl may increase the anticoagulant activities of Warfarin.
